How to buy Resonance Health (RHT) shares
Learn how to easily invest in Resonance Health shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Resonance Health Limited is a medical devices business based in Australia. Resonance Health shares (RHT) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Resonance Health has a trailing 12-month revenue of around $3.8 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Resonance Health
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Resonance Health . Find the share by name or ticker symbol: RHT. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Resonance Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Resonance Health . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Resonance Health key stats
- Compare share trading platforms
- Is Resonance Health stock a buy or sell?
- Resonance Health performance over time
- Are Resonance Health shares over-valued?
- Resonance Health 's financials
- How volatile are Resonance Health shares?
- Does Resonance Health pay a dividend?
- Have Resonance Health shares ever split?
- Other common questions
Resonance Health stock price (ASX:RHT)Use our graph to track the performance of RHT stocks over time.
Resonance Health shares at a glance
|52-week range||$0.08 - $0.325|
|50-day moving average||$0.1038|
|200-day moving average||$0.1532|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.001|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Resonance Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Resonance Health price performance over time
|1 week (2021-11-26)||-4.55%|
|1 month (2021-11-03)||-4.55%|
|3 months (2021-09-03)||-8.70%|
|6 months (2021-06-03)||-46.15%|
|1 year (2020-12-03)||-32.26%|
|2 years (2019-12-03)||-48.78%|
|3 years (2018-12-03)||101.92%|
|5 years (2016-12-02)||262.07%|
Is Resonance Health under- or over-valued?
Valuing Resonance Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Resonance Health 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Resonance Health 's P/E ratio
Resonance Health 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 110x. In other words, Resonance Health shares trade at around 110x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Resonance Health 's EBITDA
Resonance Health 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $436,387 (£232,476).
The EBITDA is a measure of a Resonance Health 's overall financial performance and is widely used to measure a its profitability.
Resonance Health financials
|Revenue TTM||$3.8 million|
|Operating margin TTM||11.04%|
|Gross profit TTM||$3.8 million|
|Return on assets TTM||2.27%|
|Return on equity TTM||5.39%|
|Market capitalisation||$50.7 million|
TTM: trailing 12 months
Resonance Health share dividends
We're not expecting Resonance Health to pay a dividend over the next 12 months.
Have Resonance Health 's shares ever split?
Resonance Health 's shares were split on a 1:10 basis on 14 October 2003. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Resonance Health shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Resonance Health shares which in turn could have impacted Resonance Health 's share price.
Resonance Health share price volatility
Over the last 12 months, Resonance Health 's shares have ranged in value from as little as $0.08 up to $0.325. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Resonance Health 's is 0.4881. This would suggest that Resonance Health 's shares are less volatile than average (for this exchange).
Resonance Health overview
Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services in the Asia Pacific, North America, Europe, the Middle East, and Africa. Its principal product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration (LIC). The company also provides FerriSmart, an artificial intelligence (AI) driven system for the automated real-time measurement of LIC; HepaFat-AI, an AI driven system for the automated real-time multi-metric measurement of liver fat; Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a non-invasive MRI-based solution for the measurement of volume fraction of fat in liver tissue; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. In addition, it offers imaging core laboratory and support services for clinical trials. The company serves clinicians for the diagnosis and management of human diseases; and pharmaceutical companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.
Stocks similar to Resonance Health
Resonance Health in the news
Resonance Health : THALASSEMIA INTERNATIONAL FEDERATION TO DEPLOY FERRISMART
Frequently asked questions
More guides on Finder
Travel insurance & COVID: How will Omicron impact my policy?
Find out what is and isn’t covered by insurance if Omicron impacts your travel plans.
How to invest in the Allup Silica IPO
Everything we know about the Allup Silica IPO, plus information on how to buy in.
The best products to achieve the clean beauty look
From where the no-makeup makeup look meets the model off duty vibe, we've put together a range of no-fuss products you'll love.
Where to watch Moulin Rouge! online in Australia
Every man wanted her – 1 man dared to love her.
How to watch Man United vs Arsenal Premier League live and match preview
Manchester United are scrambling to stay in touch with the top 4 as they host Arsenal this week
12-day advent calendars you can still get before Christmas
From toys to socks to beauty items, these are the top 12-day advent calendars you can still enjoy in the lead up to Christmas.
McDonald’s (MCD) share price, company profile and news
Steps to owning and managing McDonald's shares from in Australia.
Reputation & Christmas parties: Why I won’t be having a festive celebration this year
Reputation + Christmas parties: could it be the potential volcano erupting leaving rands, families and individuals to deal with the fallout?
Pay-as-you-groan: On-demand insurance that pays you $2K for a broken arm
Insurtech Flip has shaken up the insurance industry by launching the first on-demand injury cover in the country.
Ask an Expert